A J Bilchik

Summary

Affiliation: John Wayne Cancer Institute
Country: USA

Publications

  1. ncbi request reprint Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes
    Roderick R Turner
    Department of Pathology, Saint John s Health Center, Santa Monica, Calif, USA
    Arch Pathol Lab Med 127:673-9. 2003
  2. ncbi request reprint Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms
    A J Bilchik
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
    Ann Surg Oncol 8:82S-85S. 2001
  3. ncbi request reprint Prospective multicenter trial of staging adequacy in colon cancer: preliminary results
    Anton J Bilchik
    John Wayne Cancer Institute and Saint Johns Health Center, Santa Monica, CA 90404, USA
    Arch Surg 141:527-33; discussion 533-4. 2006
  4. ncbi request reprint Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update
    Anton J Bilchik
    John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    Cancer Control 10:219-23. 2003
  5. ncbi request reprint Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer
    Anton J Bilchik
    Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    J Clin Oncol 21:668-72. 2003
  6. ncbi request reprint Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial
    Anton J Bilchik
    Department of Gastrointestinal Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, and Michigan State University McLaren Regional Medical Center, Flint, MI, USA
    Ann Surg 246:568-75; discussion 575-7. 2007
  7. ncbi request reprint Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis
    A J Bilchik
    The John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Eur J Cancer 38:977-85. 2002
  8. ncbi request reprint Arterial chemotherapy as adjuvant and palliative treatment of hepatic colorectal metastases: an update
    Anton J Bilchik
    John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Surg Oncol Clin N Am 12:193-210. 2003
  9. ncbi request reprint The use of molecular profiling of early colorectal cancer to predict micrometastases
    Anton J Bilchik
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Arch Surg 137:1377-83. 2002
  10. ncbi request reprint Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil
    A J Bilchik
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Clin Colorectal Cancer 1:36-42. 2001

Detail Information

Publications66

  1. ncbi request reprint Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes
    Roderick R Turner
    Department of Pathology, Saint John s Health Center, Santa Monica, Calif, USA
    Arch Pathol Lab Med 127:673-9. 2003
    ..Nodal staging accuracy is important for prognosis and selection of patients for chemotherapy. Sentinel lymph node (SLN) mapping improves staging accuracy in breast cancer and melanoma and is being investigated for colorectal carcinoma...
  2. ncbi request reprint Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms
    A J Bilchik
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
    Ann Surg Oncol 8:82S-85S. 2001
    ..Our cumulative experience indicates that focused analysis of the SLNs draining GI neoplasms can increase the detection of micrometastases and may improve selection of patients for adjuvant treatment...
  3. ncbi request reprint Prospective multicenter trial of staging adequacy in colon cancer: preliminary results
    Anton J Bilchik
    John Wayne Cancer Institute and Saint Johns Health Center, Santa Monica, CA 90404, USA
    Arch Surg 141:527-33; discussion 533-4. 2006
    ..A 25% recurrence rate in patients with node-negative CRC suggests that current staging practices are inadequate. Focused analysis of the sentinel node (SN) by multiple sectioning and immunohistochemistry improves staging accuracy...
  4. ncbi request reprint Lymphatic mapping and sentinel node analysis to optimize laparoscopic resection and staging of colorectal cancer: an update
    Anton J Bilchik
    John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    Cancer Control 10:219-23. 2003
    ..Lymphatic mapping (LM) and sentinel lymph node (SLN) analysis can improve the accuracy of staging in open colectomy, but its utility during laparoscopic colectomy is unknown...
  5. ncbi request reprint Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer
    Anton J Bilchik
    Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    J Clin Oncol 21:668-72. 2003
    ..This study examined the role of lymphatic mapping (LM) in the application of the new tumor-node-metastasis (TNM) classification for MM and ITC...
  6. ncbi request reprint Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial
    Anton J Bilchik
    Department of Gastrointestinal Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, and Michigan State University McLaren Regional Medical Center, Flint, MI, USA
    Ann Surg 246:568-75; discussion 575-7. 2007
    ..6% rate of micrometastases (MM) identified by immunohistochemical staining (IHC) of H&E-negative SNs in CC. We hypothesized that these MM have prognostic importance...
  7. ncbi request reprint Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis
    A J Bilchik
    The John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Eur J Cancer 38:977-85. 2002
    ..This may have important implications when selecting patients for adjuvant treatment protocols...
  8. ncbi request reprint Arterial chemotherapy as adjuvant and palliative treatment of hepatic colorectal metastases: an update
    Anton J Bilchik
    John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Surg Oncol Clin N Am 12:193-210. 2003
    ..Molecular analysis of the tumor may ultimately help select patients who are good candidates for regional chemotherapy...
  9. ncbi request reprint The use of molecular profiling of early colorectal cancer to predict micrometastases
    Anton J Bilchik
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Arch Surg 137:1377-83. 2002
    ..Lymphatic mapping followed by focused analysis of the sentinel node is highly accurate in identifying micrometastases...
  10. ncbi request reprint Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil
    A J Bilchik
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Clin Colorectal Cancer 1:36-42. 2001
    ..These data indicate that CSA offers an effective alternative for unresectable patients resistant to 5-FU. Systemic CPT-11 or regional FUDR may further prolong survival after CSA...
  11. ncbi request reprint Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial
    A J Bilchik
    Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    J Clin Oncol 19:1128-36. 2001
    ..We hypothesized that multimarker reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of sentinel lymph nodes (SNs) draining a primary CRC could detect micrometastases not detected by conventional histopathologic analysis...
  12. ncbi request reprint Radiofrequency ablation of unresectable hepatic malignancies: lessons learned
    A J Bilchik
    Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Oncologist 6:24-33. 2001
    ..Complications may be minimized when these approaches are selectively applied...
  13. ncbi request reprint Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm
    A J Bilchik
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, Calif 90404, USA
    Arch Surg 135:657-62; discussion 662-4. 2000
    ..Thermal ablation of unresectable hepatic tumors can be achieved by cryosurgical ablation (CSA) or radiofrequency ablation (RFA). The relative advantages and disadvantages of each technique have not yet been determined...
  14. ncbi request reprint Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques
    T F Wood
    John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Ann Surg Oncol 8:150-7. 2001
    ..During LCR, colonoscopic injection can be used to mark the primary tumor and define the lymphatic drainage so that adequate resection margins are obtained. These LM techniques improve staging accuracy in CRC...
  15. ncbi request reprint Lymphatic mapping improves staging during laparoscopic colectomy for cancer
    T F Wood
    The John Wayne Cancer Institute, Saint John's Health Center, Department of Surgical Oncology, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Surg Endosc 15:715-9. 2001
    ..Focused examination of SN identifies occult micrometastases that up-stage CRC...
  16. ncbi request reprint Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial
    M H Chung
    John Wayne Cancer Institute, Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, California, 90404, USA
    Surg Endosc 15:1020-6. 2001
    ..CONCLUSION: Laparoscopic RFA and intraoperative ultrasound constitute a safe and accurate method for ablation of unresectable hepatic tumors...
  17. ncbi request reprint Repeat hepatic cryotherapy for metastatic colorectal cancer
    M H Chung
    John Wayne Cancer Institute, Santa Monica, Calif 90404, USA
    J Gastrointest Surg 5:287-93. 2001
    ..However, a prospective trial is needed to validate the efficacy of systemic therapy and to better define the indications for repeat hepatic cryotherapy...
  18. ncbi request reprint Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases
    David A Litvak
    Division of Surgical Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, California, USA
    Ann Surg Oncol 9:148-55. 2002
    ..This study evaluated our 7-year experience treating unresectable colorectal cancer (CRC) hepatic metastases refractory to systemic 5-fluorouracil...
  19. pmc Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial
    Kazuo Koyanagi
    Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Clin Cancer Res 14:7391-6. 2008
    ..Nodal micrometastasis and circulating tumor cells detected by multimarker quantitative real-time reverse transcription-PCR (qRT-PCR) may have prognostic importance in patients with colorectal cancer...
  20. ncbi request reprint Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?
    Aziz Ahmad
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
    Am Surg 72:875-9. 2006
    ..Newer-generation probes are associated with lower rates of margin recurrence and higher rates of disease-free survival after RFA of hepatic metastases from colorectal cancer...
  21. ncbi request reprint CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer
    N Habal
    Sonya Valley Ghidossi Vaccine Laboratory of the Roy E. Coats Research Laboratories, Santa Monica, California 90404, USA
    Ann Surg Oncol 8:389-401. 2001
    ..These responses correlate with overall survival. This novel therapeutic regimen for patients with advanced colon cancer merits further investigation...
  22. ncbi request reprint Thermal ablation of hepatic malignancy: useful but still not optimal
    M B Nicholl
    Department of Gastrointestinal Surgery, John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Eur J Surg Oncol 34:318-23. 2008
    ..Although radiofrequency ablation is currently the most widely used thermal ablative technique for hepatic malignancy, microwave ablation is gaining popularity and eventually may prove to be more effective...
  23. ncbi request reprint Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases
    Aziz Ahmad
    John Wayne Cancer Institute at Saint John s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
    Arch Surg 142:526-31; discussion 531-2. 2007
    ..Multimodal treatment consisting of repeated hepatectomy and adjuvant systemic chemotherapy for liver-confined recurrence of colorectal cancer can yield long-term survival comparable with that associated with primary hepatectomy...
  24. ncbi request reprint Lymphatic mapping and sentinel node analysis in colon cancer
    Steve R Martinez
    John Wayne Cancer Institute, Santa Monica, CA 90404, USA
    Clin Colorectal Cancer 4:320-4. 2005
    ..The prognostic significance of micrometastatic disease detected via ultrastaging techniques remains controversial...
  25. ncbi request reprint One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases
    Thomas F Wood
    John Wayne Cancer Institute, Santa Monica, CA 90404, USA
    J Gastrointest Surg 6:322-9; discussion 229-30. 2002
    ..Further studies are necessary to elucidate the clinical relevance of these micrometastases...
  26. ncbi request reprint Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer
    Carlos A Perez
    Laboratory of Glyco Immunotherapy, John Wayne Cancer Institute, Santa Monica, California 90404 23023, USA
    Cancer J 8:55-61. 2002
    ..We hypothesized that TA90-IC status and serum ganglioside levels might be useful markers and might be of prognostic significance in colorectal cancer...
  27. ncbi request reprint Quality control issues in the management of colon cancer patients
    S R Martinez
    Department of Gastrointestinal Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Eur J Surg Oncol 31:616-29. 2005
    ..We seek to identify those issues most relevant to the quality of care we provide our colon cancer patients...
  28. ncbi request reprint Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver
    M H Chung
    John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA
    Surgery 130:954-62. 2001
    ..CONCLUSIONS: Hepatic surgical cytoreduction can palliate progressive symptoms associated with liver metastases from intractable neuroendocrine tumors. Postoperative adjuvant therapy with octreotide LAR can prolong symptom-free survival...
  29. ncbi request reprint A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy
    George J Tsioulias
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
    Am Surg 68:561-5. 2002
    ..Focused pathologic examination of this node can upstage CRC and thereby may improve selection of patients for adjuvant chemotherapy...
  30. ncbi request reprint The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases
    Steve R Martinez
    Department of Surgical Oncology, Division of Gastrointestinal Surgery, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Am J Surg 191:281-3. 2006
    ..Hepatic metastases from breast cancer signal a dismal prognosis, with a median survival of 9.5 months...
  31. ncbi request reprint Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM
    Mepur H Ravindranath
    Laboratory of Glycoimmunotherapy, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404 2302, USA
    Cryobiology 45:10-21. 2002
    ..The post-CSA decline in the STG level correlated with the increase in the antibodies, suggesting a homeostatic role of the antibodies...
  32. pmc Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome
    Joseph Kim
    Department of Molecular Oncology, Gastrointestinal Cancer Section, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    Ann Surg 244:113-20. 2006
    ..To determine the role of chemokine receptor (CR) expression in patients with melanoma and colorectal cancer (CRC) liver metastases...
  33. pmc More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study
    Steven L Chen
    Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA 90404, USA
    Ann Surg 244:602-10. 2006
    ..To determine whether analyzing more lymph nodes in colon cancer specimens improves survival...
  34. doi request reprint Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial
    Nabil Wasif
    John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Surgery 147:352-7. 2010
    ..We sought to investigate the correlation of clinicopathologic features of colon cancer with OMs and to identify predictors of OM...
  35. ncbi request reprint Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment
    Steven D Trocha
    Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Am Surg 69:918-22. 2003
    ..Nodal expression of TS may be important in predicting response to 5-fluorouracil when a primary CRC is TS-negative...
  36. pmc Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases
    Donald L Morton
    Roy E Coats Research Laboratories of the John Wayne Cancer Insstitute at Saint John s Health Center, Santa Monica, CA 90404, USA
    Ann Surg 238:538-49; discussion 549-50. 2003
    ....
  37. pmc Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins
    J Kim
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Gut 55:1598-605. 2006
    ..Despite intent to cure surgery with negative resection margins, locoregional recurrence is common in pancreatic cancer...
  38. ncbi request reprint Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
    Joseph Kim
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    J Clin Oncol 23:2744-53. 2005
    ..Our hypothesis was that the chemokine receptor CXCR4 expressed by CRC is a prognostic factor for poor disease outcome...
  39. ncbi request reprint Lymphatic mapping and sentinel node analysis: current concepts and applications
    Steven L Chen
    Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA
    CA Cancer J Clin 56:292-309; quiz 316-7. 2006
    ..Variations on techniques specific to each organ are explained, and the current role of sentinel node biopsy in diagnosis and treatment is discussed...
  40. ncbi request reprint Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer
    Steven D Trocha
    Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA
    J Gastrointest Surg 7:340-5; discussion 345-6. 2003
    ....
  41. ncbi request reprint Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes
    Bret Taback
    Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    Int J Cancer 111:409-14. 2004
    ..This study demonstrates the utility, specificity and sensitivity of PNA clamp PCR assay in identifying occult micrometastases in the SLN of CRC patients by single-base mutation analysis...
  42. ncbi request reprint Long-term survival after radiofrequency ablation of complex unresectable liver tumors
    Farin F Amersi
    John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, Calif 90404, USA
    Arch Surg 141:581-7; discussion 587-8. 2006
    ..Radiofrequency ablation (RFA) may improve survival of high-risk patients with unresectable and refractory tumors...
  43. ncbi request reprint Treatment disparities in Hispanic rectal cancer patients: a SEER database study
    Steve R Martinez
    Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Am Surg 72:906-8. 2006
    ..Further studies are required to assess the impact of these treatment disparities on patient outcome...
  44. ncbi request reprint Historical review of lymphatic mapping in gastrointestinal malignancies
    Sukamal Saha
    Departments of Surgery, Michigan State University and McLaren Regional Medical Center, Flint, Michigan, USA
    Ann Surg Oncol 11:245S-9S. 2004
    ..Over the past 2 years, research and publications related to gastrointestinal lymphatic mapping have dramatically increased worldwide...
  45. ncbi request reprint The clinical significance of MAGEA3 expression in pancreatic cancer
    Joseph Kim
    Gastrointestinal Research Section, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA 90404, USA
    Int J Cancer 118:2269-75. 2006
    ..Molecular assessment for MAGEA3 should be considered to improve prognostic evaluation and to identify eligible patients for potential immune-based therapy...
  46. ncbi request reprint Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note
    Anton J Bilchik
    John Wayne Cancer Institute at St John s Health Center, Santa Monica, CA, USA
    J Clin Oncol 23:9073-8. 2005
  47. ncbi request reprint Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma
    Naoyuki Umetani
    Department of Molecular Oncology, John Wayne Cancer Institute, Saint Johns Health Science Center, Santa Monica, CA 90404, USA
    Oncogene 23:8292-300. 2004
    ..MIN was observed in 11 of 49 (23%) primary CRCs and was a favorable prognostic factor. Our results suggest that APAF-1 gene haploinsufficiency caused by AI increases with tumor progression, and relates to hepatic metastasis...
  48. ncbi request reprint Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned
    Richard J Bleicher
    John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, California 90404, USA
    Ann Surg Oncol 10:52-8. 2003
    ..Radiofrequency ablation (RFA) is a promising technique for unresectable hepatic malignancies. We reviewed our RFA experience to identify variables affecting local recurrence...
  49. ncbi request reprint Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats
    Naoyuki Umetani
    Department of Molecular Oncology and Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA 90404, USA
    Clin Chem 52:1062-9. 2006
    ..We developed a novel method to measure the ratio of longer to shorter DNA fragments (DNA integrity) in serum as a potential biomarker for patients with colorectal cancer (CRC) or periampullary cancers (PACs)...
  50. ncbi request reprint New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference
    Lee S Rosen
    Premiere Oncology, Santa Monica, CA 90404, USA
    Clin Cancer Res 13:6853s-6s. 2007
    ....
  51. ncbi request reprint Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?
    Byron E Wright
    Department of Surgical Oncology, Division of Gastrointestinal Surgical Oncology, John Wayne Cancer Institute at St John s Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Am J Surg 194:820-5; discussion 825-6. 2007
    ..Although reported survival for localized T2 disease has been poor, groups have documented improvement with radical resection. We hypothesized that a discrepancy exists between national recommendations and current practice patterns...
  52. ncbi request reprint Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy
    David A Litvak
    Division of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California 90404, USA
    J Gastrointest Surg 7:140-8; discussion 148. 2003
    ..Blocking further metabolism of ceramide can enhance this cytotoxicity. Targeting ceramide pathways is a novel strategy for the treatment of patients with CRC...
  53. ncbi request reprint Hepatic cytoreductive surgery for neuroendocrine cancer
    Byron E Wright
    Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, USA
    Surg Oncol Clin N Am 16:627-37, ix-x. 2007
    ....
  54. ncbi request reprint Colorectal cancer screening and surveillance: current standards and future trends
    Steve R Martinez
    Division of Surgical Oncology, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, California 90404, USA
    Ann Surg Oncol 13:768-75. 2006
    ....
  55. ncbi request reprint Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis
    Naoyuki Umetani
    Department of Molecular Oncology, and Division of Gastrointestinal Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
    Clin Cancer Res 10:7475-83. 2004
    ..The epigenetic inactivation of ID4 gene on colorectal cancer (CRC) development and its clinical significance was assessed...
  56. ncbi request reprint Resecting lymph nodes in colon cancer: more than a staging operation?
    Steven L Chen
    Ann Surg Oncol 14:2175-6. 2007
  57. doi request reprint Urgent need for a new staging system in advanced colorectal cancer
    Graeme J Poston
    Department of Surgery, University Hospital Aintree, Liverpool, L9 7AL, United Kingdom
    J Clin Oncol 26:4828-33. 2008
    ....
  58. ncbi request reprint Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
    Anton J Bilchik
    J Clin Oncol 26:1786-8. 2008
  59. pmc Significance of the lymph node ratio in stage III colon cancer
    Simon H Telian
    Ann Surg Oncol 15:1557-8. 2008
  60. ncbi request reprint Sentinel lymph node mapping with GI cancer
    Takashi Aikou
    Department of Surgical Oncology and Digestive Surgery, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan
    Cancer Metastasis Rev 25:269-77. 2006
    ..Although more evidence from large-scale multicenter clinical trials is required, SLN mapping may be very useful for individualizing multi-modal treatment for esophageal cancer and might be widely acceptable even for GI cancer...
  61. ncbi request reprint Improving resectability of hepatic colorectal metastases: expert consensus statement
    Eddie K Abdalla
    The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Ann Surg Oncol 13:1271-80. 2006
  62. pmc Close collaboration between surgeon and pathologist is essential for accurate staging of early colon cancer
    Anton J Bilchik
    Ann Surg 245:864-6. 2007
  63. ncbi request reprint Is routine use of sentinel node biopsy justified in colon cancer?
    Michael Nicholl
    Ann Surg Oncol 15:1-3. 2008
  64. ncbi request reprint Novel effective drugs and evolving ablation technology: a more comprehensive approach to hepatic malignancies
    Anton J Bilchik
    Ann Surg Oncol 11:458-9. 2004
  65. ncbi request reprint Radiofrequency ablation of hepatic malignancies: inexpensive and minimally invasive but should it replace resection?
    Anton J Bilchik
    Ann Surg Oncol 10:1002-4. 2003
  66. ncbi request reprint Lymphatic mapping of nodal micrometastasis in colon cancer: putting the cart before the horse?
    Anton J Bilchik
    Ann Surg Oncol 9:529-31. 2002